Abstract:The majority of patients with non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations inevitably progress in stage despite an initial substantial and rapid response to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). Previous research indicates that hypoxia may be associated with resistance to EGFR-TKIs in EGFR mutation-positive NSCLC. Therefore, the present study regulated the activity of hypoxia-inducible factor-1 (HIF-1) signaling pathway to observe if it is able to alter the sensitivity of lung cancer cells to gefitinib. The present study selected 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) and dimethyloxalylglycine (DMOG) as a HIF-1 signaling pathway inhibitor and activator, respectively, on HCC827 cells. Cells were incubated with different treatments for different durations: A blank control, DMOG, gefitinib, or DMOG and gefitinib combined, for 36 and 48 h; and then a blank control, YC-1, gefitinib, or YC-1 and gefitinib combined, for 16 and 28 h. A western blot analysis assay was performed to evaluate the protein expression levels of HIF-1α and phosphorylated hepatocyte growth factor receptor (p-MET), an MTT assay was used to determine cell proliferation, a colony formation assay was used to investigate the colony-forming ability and a wound healing assay was used to test the cell migration ability. Additionally, Pearson's correlation analysis was used to evaluate the correlation between p-Met and HIF-1α expression levels. Finally, it was identified that gefitinib and DMOG combined notably improve the growth and cell migration ability of HCC827 cells, compared with gefitinib alone. When gefitinib and YC-1 were combined, the inhibiting effect on the growth and cell migration ability of HCC827 cells was substantially enhanced, compared with the control cells. Pearson's correlation analysis revealed that the p-Met expression level had a strong positive correlation with HIF-1α expression levels. Thus, it was concluded that the HIF-1 signaling pathway influences the sensitivity of HCC827 cells to gefitinib. The positive correlation between p-Met and HIF-1α expression levels may be the underlying mechanism of the HIF-1 signaling pathway influencing the sensitivity of HCC827 cells to gefitinib.

Preliminary Study on HCC EMT Transformation and Drug Resistance Induced by Hypoxia

The Impact of Hypoxia Improvement on Laryngeal Squamous Cell Carcinoma Chemotherapy

Effects of Hypoxia on Malignant Phenotype of HCC Cells

Epithelial–mesenchymal Transition Plays a Critical Role in Drug Resistance of Hepatocellular Carcinoma Cells to Oxaliplatin

Effects of Hypoxia on Chemotherapeutic Drug-induced Apoptosis of Hepatocellular Carcinoma Cells

Activation Of Pi3 Kinase/Akt/Hif-1 Alpha Pathway Contributes To Hypoxia-Induced Epithelial-Mesenchymal Transition And Chemoresistance In Hepatocellular Carcinoma

Data from Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis

Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma

Hypoxia-inducible Factor-1 Signaling Pathway Influences the Sensitivity of HCC827 Cells to Gefitinib.

Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery

Hypoxia induces stemness properties in hepatocellular carcinoma cells

Hepatic arterial occlusion promotes epithelial-mesenchymal transition of peritumoral liver cells in hepatocellular carcinoma

Hypoxia Induces Epithelial-Mesenchymal Transition Via Activation of SNAI1 by Hypoxia-Inducible Factor -1Α in Hepatocellular Carcinoma.

Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.

The diverse changes of βcatenin induced by hypoxia in hepatocellular carcinoma

Hypoxia Induces Universal but Differential Drug Resistance and Impairs Anticancer Mechanisms of 5-Fluorouracil in Hepatoma Cells.

Study on the function of HIF-1 and ASK1 in the formation of chemotherapy resistance of hepatoma cell line SMMC-7721 during hypoxia

Sa1469 - The Early Molecular Events for Multi-Focal Hepatocellular Carcinoma

Effect of Hypoxia on Epithelia-mesenchymal Transition of Prostate Cancer PC3 Cells

Effect of hepatic stellate cell condition medium on chemo-resistance of hepatocellular carcinoma PLC/PRF/5 cells and its mechanism

Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.